| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |